Influence of Cardiometabolic Status on Cardiovascular Effects of Oral Menopausal Hormone Therapy
Obstetrics & Gynecology
•
January 01, 2026
Cholesterol modifies oral hormone heart risk
Baseline cholesterol levels helped identify women at higher heart risk from oral menopausal hormone therapy. *Secondary subgroup analysis of randomized trials; Level 2 (OCEBM).
- Level of evidence
- Level 2 (OCEBM)
- DocG quality score
- 7.3 / 10
Read the full summary free
Patients, intervention, outcomes, results, and clinical applicability in about 300 words — plus new summaries in your inbox 3× per week.
Sign in with Google
